SEC Form 4 · accession 0001209191-18-003725
BlackRock Health Sciences Trust · BME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Cavanagh
Director
Period of report
Jan 12, 2018
Accepted (ET)
Jan 17, 2018 · 9:06 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314966
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance RightsF1,F2,F3 | — | Jan 12, 2018 | A | 123 | A | — | — | Common Stock | 123 | 1,272 | D |
Explanation of responses
- F1The Performance Rights were accrued under the BlackRock Deferred Compensation Plan.
- F2One Performance Right is convertible into the cash value of one share of BlackRock Health Sciences Trust.
- F3The Performance Rights are to be settled 100% in cash at the deferral period chosen by the reporting person.